Stocks Special Reports LICs Hybrids Technical Analysis Funds ETFs Tools SMSFs
Learn
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features Hybrids Technical Analysis SMSFs Learn Fund Times Ask the Analyst China Wrap
About

Company News Summary

ResMed Appoints CEO

27 Feb 2013  |  14:12:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: ResMed Appoints CEO & COO

ResMed reported that on February 20, 2013, the board approved the appointment of Michael Farrell as the company's CEO, to be effective March 1, 2013. Mr. Farrell has served as the company's president - Americas since May 2011. In addition to his appointment as CEO, Mr. Farrell was appointed to serve as a director on the board effective as of March 1, 2013. At this time, the company does not expect Mr. Farrell to serve on any of the board's committees. On February 20, 2013, and in connection with the appointment of Mr. Farrell as CEO, the board determined that Peter Farrell, the current chairman of the board, president, and CEO of the company, will serve solely as executive chairman of the board effective as of March 1, 2013.

Please click here for full details

See more ASX300 News Announcements